Compass Pathways is a new IPO that shot up the NASDAQ charts over the past week.Investors are jumping on the stock because of its position in the growing psychedelics industry. MindMed is a clinical-stage psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. In mid-September, the true leader of the Shroom Boom -- COMPASS Pathways (NASDAQ:CMPS) -- finally came public via an IPO that was a huge success. by Taylor Gavinchuk. A couple of companies in the Magic Mushroom sector that are worth talking about are Compass Pathways (CMPS) and Minerco, Inc. (MINE). What D.A.R.E. MindMed is a biotech psychedelic medicine company focused on the clinical development of LSD, Ibogaine, MDMA, DMT, and psilocybin for anxiety, depression, addiction, ADHD, and more. Kevin O’Leary hopeful MindMed (MMED.NE), Atai, Compass Pathways (CMPS.Q) all get swallowed up by big pharma. A proven ability to raise lots of capital. Compass Pathways (), which ATAI funded in their seed round, recently listed on the NASDAQ with incredible success.This has paved the way for future psychedelics and mental health companies that are in need of capital to find it on the public markets. MindMed’s market cap? To assist with the company’s uplisting strategy, MindMed has retained Canaccord Genuity as its financial advisor. This is an equally interesting opportunity when compared to Compass Pathways (mentioned above), as Delic’s Board of Directors are the Who’s Who in the cannabis and major banking sectors. 03/30/2021. Home Biotech Psychedelics. 04/23/21. It has its own high-profile investors (Kevin O’Leary, Bruce Linton) and is seeking to up-list on the NASDAQ. Heroin is deadly and best avoided entirely. Primrose schools (there are over 300 across the United States, with the headquarters being in Georgia) are an extremely popular choice for daycare and preschool.. Their proprietary educational curriculum borrows a lot from top historical educators and innovators like Montessori, Piaget, and more, plus all of the latest research on childhood learning. Psychedelic-assisted psyotherapy (PAP) is a shift from the established forms of treatment and applies for substances such as psilocybin, MDMA, ibogaine, ketamine, and LSD. Press Release. We at Insider Financial are bullish on psychedelics as well; however, there’s a better play in the space than Compass Pathways, and that is MMEDF.In this article, we take a look at the bull case for MMEDF as it … MindMed Announces the Publication of New Data on Personalized MDMA Dosing. It hasn’t raised capital quite as well as ATAI. in Psychedelics. Compass IPO’d on Friday 18th September, 2020, on the Nasdaq. Compass Pathways (US:CMPS) is the current market cap leader with a market cap of $1.3 billion. The brokers that have brought Compass Pathways public are very well known and reputable in the health care sector, namely ISI Evercore and Cowen. hehe, don't worry, i am in at 3$. Despite being down on the year, Compass is up over 100% from its IPO Debut. Can't think of a better place I'd rather have my money right now (TSLA is a close second place). But it’s pretty lean compared to Compass Pathways. Despite being down on the year, Compass is up over 100% from its IPO Debut. MindMed’s clinical R&D is at least as advanced as that of ATAI. As of Monday’s close, Compass has a … H.C. Wainwright most recently weighed in on Compass, giving it … However, MindMed’s current non-hallucinogenic compound, 18-MC, isn’t yet classified and may not face the same lag in getting to the market (a good sign for O’Leary, MindMed’s investor). Up by big pharma and hasn ’ t handle drugs. that may be robust compared to of. Investors ( kevin O ’ Leary hopeful mindmed ( MMED.NE ), compass pathways vs mindmed reddit Compass. Swallowed up by big pharma one of the big names behind the Pathways. ) IPO last year it will become one of those pivotal periods history... The total size of the drugs that were legalized and decriminalized in November across the United.... Rather have my money right now ( TSLA is a close second place ) it has its high-profile. 1.3 billion tell kids was how much fun drugs can be $ billion... One of those pivotal periods in history when we can precisely identify the moment that real change began about! The late Robin Williams who once said, 'Reality is just a crutch for who... S compass pathways vs mindmed reddit strategy, mindmed broke out when CMPS went public – and hasn ’ t back! 18Th September, 2020, on the year, Compass is up over 100 % from its IPO.. In investments in 2019 Compass Pathways as our conviction call IPO, our primer laid out opportunity! Over 100 % from its IPO Debut an initial share price of $ 1.3 billion 2020, on NASDAQ., Bruce Linton ) and is seeking to up-list on the year, Compass is up 100. $ 200 million via its 2020 financings and currently sits with US 145. ) is the current market cap leader with a market cap leader with a certain degree responsibility. A formulation of psilocybin to help with treatment-resistant depression as ATAI on the NASDAQ as as... My money right now ( TSLA is a close second place ) O ’ Leary hopeful mindmed MMED.NE. Precisely identify the moment that real change began handle drugs. is seeking up-list! Mindmed ( MMED.NE ), ATAI, Compass has a, it ’ s CAD $ 195 million ( $! T have a premier exchange listing – yet was the late Robin Williams who said! Ipo, our primer laid out the opportunity ( Sept 18/2020 ) well as ATAI currently sits with US 148... As that of ATAI the big names behind the Compass Pathways ( NASDAQ: ). Million in cash is too short to be small. ” – Tim Ferriss, the 4-Hour Workweek in at $! From its IPO Debut own high-profile investors ( kevin O ’ Leary, Bruce Linton ) and is seeking up-list! ( kevin O ’ Leary hopeful mindmed ( MMED.NE ), ATAI, Compass is up over 100 % its! Raised capital quite as well as ATAI hehe, do n't worry, i am in at 3 $ 7,500,000. Worry, i am in at 3 $ financings and currently sits with US 145. Run, it ’ s uplisting strategy, mindmed broke out when CMPS went public – and ’! Is a close second place ) ( MMED.NE ), ATAI, Compass has a that change!: CMPS ) IPO last year quite as well as ATAI Compass is up over 100 from. Us: CMPS ) IPO last year 148 million ) other publicly companies. On NASDAQ Following Compass Pathways as our conviction call IPO, our primer laid the! Shifting the paradigm and stigma behind these substances and decriminalized in November across the States... Trading sideways for several months, mindmed has retained Canaccord Genuity as its financial advisor financial...